Showing 1 - 20 results of 233 for search '"trastuzumab"', query time: 0.73s Refine Results
  1. 1
    by Jia-Jung Hsu, 許嘉容
    Published 2012
    .... Trastuzumab resistance cause relapse of the tumor or dosing mass anti-cancer drug is a major obstacle...
    Get full text
    Others
  2. 2
    by Sy, Jonathan Tiu
    Published 2010
    ... and antigen binding specificity. Trastuzumab, a monoclonal antibody that targets the HER2 receptor, has been...
    Get full text
  3. 3
    by Sy, Jonathan Tiu
    Published 2010
    ... and antigen binding specificity. Trastuzumab, a monoclonal antibody that targets the HER2 receptor, has been...
    Get full text
  4. 4
    by Balachandran, Banujan
    Published 2013
    ...-bound receptor tyrosine kinase upstream of crucial proliferation and cell survival pathways. Trastuzumab...
    Get full text
    Others
  5. 5
    by Triulzi, Tiziana
    Published 2017
    ...Despite the clinical benefit of trastuzumab, some patients do not respond to this therapy. Aims...
    Get full text
  6. 6
    by Sy, Jonathan Tiu
    Published 2010
    ... and antigen binding specificity. Trastuzumab, a monoclonal antibody that targets the HER2 receptor, has been...
    Get full text
  7. 7
    by Hsu-ChihChien, 錢叙芝
    Published 2016
    ... of trastuzumab in the Asian population is limited. This thesis is thus aimed to describe the prescribing pattern...
    Get full text
    Others
  8. 8
  9. 9
  10. 10
    by Walker, Jonathan Robert
    Published 2010
    ...Background: In breast cancer patients, the administration of Trastuzumab and Doxorubicin...
    Get full text
  11. 11
    by Walker, Jonathan Robert
    Published 2010
    ...Background: In breast cancer patients, the administration of Trastuzumab and Doxorubicin...
    Get full text
  12. 12
    by Sundfors, Anu-Johanna
    Published 2019
    ...-positive breast cancer after progression in trastuzumab-based 1stline treatment. When T-DM1 became...
    Get full text
    Others
  13. 13
  14. 14
  15. 15
  16. 16
    by Mason, Julie
    Published 2010
    ... with two doses of a primary anti-HER2 therapy, trastuzumab (TRAS), in athymic mice. FO alone had no effect...
    Get full text
  17. 17
    by Mason, Julie
    Published 2010
    ... with two doses of a primary anti-HER2 therapy, trastuzumab (TRAS), in athymic mice. FO alone had no effect...
    Get full text
  18. 18
  19. 19
    by Thunborg, Emilia
    Published 2019
    ... In this retrospectivecohort study, the aim was to identifythe rate of exceptional respondersto trastuzumab-based therapyand...
    Get full text
    Others
  20. 20